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Abstract
Introduction An increased body mass index (BMI)
(>25kg/m2) is associated with a wide range of elec-
trocardiographic changes. However, the associa-
tion between electrocardiographic changes and BMI
in healthy young individuals with a normal BMI
(18.5–25kg/m2) is unknown. The aim of this study
was to evaluate the association between BMI and
electrocardiographic parameters.
Methods Data from 1,290 volunteers aged 18 to
30 years collected at our centre were analysed. Only
subjects considered healthy by a physician after re-
view of collected data with a normal BMI and in sinus
rhythm were included in the analysis. Subjects with
a normal BMI (18.5–25kg/m2) were divided into BMI
quartiles analysis and a backward multivariate re-
gression analysis with a normal BMI as a continuous
variable was performed.
Results Mean age was 22.7± 3.0 years, mean BMI was
22.0, and 73.4% were male. There were significant dif-
ferences between the BMI quartiles in terms of maxi-
mum P-wave duration, P-wave balance, total P-wave
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area in lead V1, PR-interval duration, and heart axis.
In the multivariate model maximum P-wave duration
(standardised coefficient (SC)= +0.112, P<0.001), P-
wave balance in lead V1 (SC= +0.072, P<0.001), heart
axis (SC= –0.164, P< 0.001), and Sokolow-Lyon voltage
(SC= –0.097, P<0.001) were independently associated
with BMI.
Conclusion Increased BMI was related with dis-
crete electrocardiographic alterations including an
increased P-wave duration, increased P-wave bal-
ance, a leftward shift of the heart axis, and decreased
Sokolow-Lyon voltage on a standard twelve lead
electrocardiogram in healthy young individuals with
a normal BMI.
Keywords BMI · ECG · Healthy · Obesity
Introduction
Obesity causes several haemodynamic changes such
as increased blood and stroke volume, and an in-
What’s new
 Obesity-associated electrocardiographic changes
are also found in healthy young individuals with
a normal bodymass index (BMI) (18.5–25kg/m2).
 There were significant differences between the
BMI quartiles in terms of maximum P-wave du-
ration, P-wave balance, total P-wave area in lead
V1, PR-interval duration, and heart axis.
 Within the normal range, an increased BMI
was independently associated with an increased
P-wave duration, increased P-wave balance,
a leftward shift of the heart axis, and decreased
Sokolow-Lyon voltage.
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crease in pulmonary and left atrial pressure [1, 2].
These changes cause structurally altered cardiac tis-
sue such as left atrial enlargement and remodelling,
and ventricular hypertrophy [1, 2]. These may ulti-
mately result in obesity-induced left ventricular dias-
tolic and systolic dysfunction and right and left ven-
tricular heart failure [1, 2].
Some obesity-induced adverse effects on cardiac
function can be identified on a 12-lead electrocardio-
gram (ECG). This includes an increased P-wave du-
ration and dispersion [3–6], prolongation of the PR
interval [3–7], low QRS voltage in the limb leads [7–9],
leftward shift of the heart axis [7–11], various mark-
ers of left ventricular hypertrophy [12–14] and pro-
longation of the corrected QT interval and prolonged
QT-interval duration [8]. Many of these electrocar-
diographic abnormalities have been reported to be
reversible with substantial weight loss thereby rein-
forcing the association between BMI and electrocar-
diographic changes [2, 8].
These electrocardiographic changes are well-doc-
umented in obese individuals. However, to which
extent these electrocardiographic changes are associ-
ated with BMI in healthy young individuals with a nor-
mal BMI (18.5–25kg/m2) is largely unknown. In addi-
tion, subtle physiological changes in these individuals
are of particular interest in early phase pharmaceuti-
cal research because they help differentiate between
normal physiological changes or potentially harmful
or unknown pharmacodynamic effects. The aim of
the present analysis was to evaluate the association
between BMI and selected electrocardiographic pa-
rameters related to cardiac alterations in obesity in
a healthy young population with a normal BMI.
Methods
Data from 1,290 male and female volunteers with
a normal BMI (18.5–25.0kg/m2) aged 18–30 years used
in the present analysis were collected at the Centre
for Human Drug Research in Leiden, the Netherlands,
a clinical research organisation specialised in early-
phase drug development studies. Data from studies
that were performed in healthy volunteers between
2010 and 2016 were included in the present anal-
ysis. For all studies, healthy volunteers underwent
a mandatory medical screening to verify eligibility
for the study. The present analysis was performed
in accordance to local regulations. All activities were
performed in accordance to applicable standard op-
erating procedures.
Medical screening
The medical screening consisted of a single visit to the
clinical unit where a detailed medical history, a phys-
ical examination, vital signs including blood pressure,
temperature, weight and height measurement, BMI
calculation, and a twelve-lead electrocardiogram were
recorded. Additionally, haematology and chemistry
blood panel, urine dipstick, and a urine drug test were
recorded.
Weight and height measurement
For the weight and height measurement, the subject
was asked to undress except for underwear and asked
to stand on the platform with the back against the
measuring rod, heels against the heel board and back
and neck straight. A BMI was calculated automatically






Body weight and height measurements were re-
corded with a calibrated digital measuring rod (SECA
285; RevaMed BV, Kampen, the Netherlands) and im-
mediately entered into a validated database system
(Promasys, OmniComm, Fort Lauderdale, FL, USA).
ECG measurements
The twelve-lead ECGs were recorded with the vol-
unteer in a resting supine position and after a five-
minute resting period. The twelve-lead ECGs were
recorded using an electrocardiograph (Marquette
800/5500/2000 or Dash 3000; General Electric Health-
care, Milwaukee, USA) and twelve disposable elec-
trodes placed in the standard anatomical position.
The ECG data were then uploaded into the ECG ware-
house (Muse Cardiology DataManagement System v7,
General Electric Healthcare, Chicago, IL, USA). The
Marquette Cubic Spline and Finite Residual Filtering
filters were used for artefact and noise management.
The ECG warehouse automatically assesses interval
and amplitude data from the digital ECGs with the
Marquette 12SL algorithm, which provides a variety
of ECGmeasurements which have been used in previ-
ous studies [15, 16]. In addition, a physician reviewed
all ECGs for quality, legibility and abnormalities. In-
dependent evaluation showed that the Marquette
12SL algorithm passed all of the amplitude measure-
ment requirements (maximum of 10ms deviation)
as defined in International Electrotechnical Commis-
sion, as described in the GE Physician’s Guide (version
2036070-006). Description, methods of determination
and calculation, and units of the electrocardiographic
parameters are described in Tab. 1.
Validation cohort
Additionally, data from 255 male and female volun-
teers with an overweight BMI (25.1–30.0kg/m2) aged
18–30 years similarly collected as the data from volun-
teers with a normal BMI (18.5–25.0kg/m2) were added
to the analysis as a validation cohort. These data was
used to test the persistence of any significant vari-
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Table 1 Methods of determination or calculation of the electrocardiographic (ECG) variables used in the analysis of the
1,554 healthy volunteers aged 18 to 30 years with a body mass index (BMI) between 18.5 and 30.0kg/m2
Variable Description
Maximum P-wave duration (ms) Longest P-wave duration sampled from all leads
P-wave balance in lead V1 (µV) Difference between the upward and downward deflection of the P-wave
P-wave dispersion (ms) Difference between the longest minus the shortest P-wave duration from all leads
Total P-wave area in lead V1 (mm*ms) Sum of the total area under and above the isoelectric line from onset to termination of the P-wave [27]
PR interval (ms) Beginning of the P-wave until the beginning of the QRS complex
QRS duration (ms) First deflection from the isoelectric line following the P-wave until the J-point
Heart axis (degrees) Net vector of the R wave axis based on the extremity leads
Sokolow-Lyon voltage (mm) Sum amplitude of the S wave in lead V1 and the amplitude of the R wave in lead V5 or V6 (whichever is larger) [28]
Cornell product (ms*mm) Product of the QRS duration and the Cornell voltage [29]. Cornell voltage is the sum of the amplitude of the R wave in
lead aVL and the amplitude of the S wave in lead V3 [29]
Maximum T-wave duration (ms) Longest T-wave duration sampled from all leads
Minimum T-wave duration (ms) Shortest T-wave duration sampled from all leads
T-wave dispersion (ms) Difference between the longest and shortest T-wave duration selected from all leads
QTcF duration (ms) QTcF duration is calculated using the Fridericia formula, which divides the QT interval by the cube root of RR interval
[30]. QT interval is the interval between the start of the Q wave and the end of the T wave. RR interval is the interval
between the onset of one QRS complex to the onset of the next QRS complex, measured in seconds, derived from the
heart rate (HR) as 60/HR
mV millivolt, µV microvolt, ms milliseconds,mm millimetres, QTcF corrected QT interval with the Fridericia formula
ances of ECG findings in the healthy subjects with
a normal BMI (18.5–25.0kg/m2) in that of healthy sub-
jects with an overweight BMI (25.1–30.0kg/m2). This
data was not included in the univariate and multivari-
ate analysis.
Statistical analysis
Data are reported as mean± standard deviation (SD),
median with interquartile range or percentage where
appropriate. Categorical variables were compared us-
ing chi-squared test. Variances were compared using
the Analysis of Variance (ANOVA) test with a post-hoc
Tukey analysis. A linear univariate and a backward lin-
ear multivariate regression model analysis were per-
formed solely with the data of the subjects with a nor-
mal BMI (18.5–25.0kg/m2). Probabilities of less than
0.10 in the linear univariate regression model were
added to the backward linear multivariate regression
model. Results are reported as unstandardised coeffi-
cient (USC) and standardised coefficient (SC) with the
corresponding P value. Statistical analyses were per-
formed using IBM SPSS version 25 (IBM corporation,
Armonk, NY, USA).
Results
In total, 1,290 subjects were included in the present
analysis. Mean age was 22.6± 3.0 years, 73.9% were
male. Subjects with a normal BMI (n= 1,290) were
divided based on BMI quartiles (18.5–20.7; 20.7–22.0;
22.0–23.4; 23.4–25.0kg/m2). Overweight subjects
(n= 255) were allocated in to the overweight group.
Subject characteristics are shown in Tab. 2. Subjects
in the lowest BMI quartile were significantly younger
and had a significantly lower systolic blood pres-
sure compared with subjects in the third (P=0.003
and P< 0.001 respectively) and fourth BMI quartile
(P<0.001 and P<0.001 respectively). In addition,
overweight subjects were significantly younger than
the first quartile (P=0.003), and had a significantly
higher systolic blood pressure compared with sub-
jects in the first (P<0.001), second (P<0.001), and
third BMI quartile (P=0.006). Other baseline charac-
teristics were not significantly different among BMI
groups.
BMI and electrocardiographic parameters
Table 2 displays the association between the BMI
quartiles and the evaluated electrocardiographic pa-
rameters. Maximum P-wave duration, P-wave bal-
ance, total P-wave area in lead V1, PR interval, and
heart axis were significantly different between the
normal BMI quartiles and the overweight BMI group,
as displayed in Fig. 1.
Linear regression analysis
In the univariate analysis of the data of the subjects
with a normal BMI (18.5–25.0kg/m2), BMI was sig-
nificantly associated (P< 0.05) with age (SC=+0.139,
P< 0.001), systolic blood pressure (SC+0.146,
P< 0.001), ventricular rate (SC= –0.076, P= 0.006),
serum creatinine (SC= +0.152, P< 0.001), serumpotas-
sium (SC=+0.054, P= 0.054), maximum P-wave dura-
tion (SC= +0.130, P<0.001), P-wave balance in lead
V1 (SC=+0.077, P= 0.006), total P-wave area in lead
V1 (SC= +0.084, P= 0.003), PR interval (SC=+0.090,
P= 0.001), and heart axis (SC= –0.191, P< 0.001). In
the backward multivariate model, age (SC=+0.108,
P< 0.001), systolic blood pressure (SC=+0.173,
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Table 2 Relation between patient characteristics and electrocardiographic parameters to BMI of included healthy volunteers











Corresponding group α ß γ δ ε
Age (years) 22.2± 2.93 γ δ ε 22.6± 3.02 23.0± 2.93 α 23.1± 3.05 α 23.1± 2.89 α
Gender (% male) 70.0 72.8 76.5 75.4 77.5
Temperature (°C) 36.7± 0.35 36.7± 0.40 36.7± 0.40 36.7± 0.39 36.8± 0.39
Systolic blood pressure (mmHg) 117± 10.2 γ δ ε 119± 10.5 ε 120± 9.63 α ε 121± 10.0 α 123± 10.0 α ß γ
Diastolic blood pressure (mmHg) 67.9± 7.77 68.3± 7.74 68.6± 7.68 68.4± 7.50 69.1± 8.34
Ventricular rate (beats/min) 64.4± 9.99 62.7± 9.69 62.5± 10.6 62.6± 9.83 64.7± 10.6
Serum Sodium (mmol/l) 141± 1.82 141± 1.90 141± 1.92 141± 1.85 141± 1.91
Serum Potassium (mmol/l) 4.31± 0.33 4.33± 0.31 4.33± 0.29 4.36± 0.30 4.33± 0.30
Serum Calcium (mmol/l) 2.42± 0.09 2.42± 0.09 2.41± 0.09 2.42± 0.09 2.42± 0.10
Maximum P-wave duration (ms) 99.09± 10.4 δ ε 100.5± 11.5 δ ε 101.2± 10.7 ε 102.9± 10.6 α ß 103.8± 11.1 α ß γ
P-wave balance in lead V1 (µV) 0.31± 0.45 δ ε 0.32± 0.42 δ ε 0.33± 0.43 0.41± 0.41 α ß 0.42± 0.35 α ß
P-wave dispersion (ms) 51.5± 20.8 53.6± 19.9 52.0± 21.0 51.7± 21.3 50.9± 20.9
Total P-wave area in lead V1 (mm*ms) 47.53± 82.6 δ ε 47.15± 76.3 δ ε 50.50± 79.5 δ ε 67.91± 80.0 α ß γ 70.96± 74.0 α ß γ
PR interval (ms) 146.9± 18.1 γ δ ε 149.9± 21.9 152.2± 21.0 α 151.5± 20.7 α 153.1± 19.0 α
QRS duration (ms) 96.0± 10 96.4± 10 97.7± 10 97.0± 10 96.9± 10
Heart axis (degrees) 68.65± 25.8 γ δ ε 63.90± 26.0 δ ε 59.77± 27.0 α ε 54.57± 28.3 α ß 51.91± 28.2 α ß γ
Sokolow-Lyon voltage (mm) 28.02± 8.28 27.30± 7.78 27.83± 8.27 26.80± 7.69 26.77± 7.66
Cornell product (mm*µV) 11.45± 6.29 12.29± 6.52 12.47± 6.21 11.74± 5.78 12.07± 6.09
Maximum T-wave duration (ms) 183± 20 184± 20 182± 20 183± 20 181± 21
Minimum T-wave duration (ms) 107± 54 115± 52 110± 49 114± 51 109± 50
T-wave dispersion (µV) 75.9± 54.7 69.4± 52.9 72.5± 54.7 68.3± 51.8 72.4± 50.5
QTcF duration (ms) 404.8± 17 406.7± 18 405.4± 18 405.1± 19 404.0± 19
Categorical variables were compared using chi-squared test, variances were compared using the Analysis of Variance test with a post hoc Tukey analysis.
Results are reported as mean± SD or as percentage. The symbols α, ß, γ, δ, and ε represent a significant difference (P< 0.05) compared with that group. If no
symbols are present, no significance was found between the groups
mV millivolt, µV microvolt, ms milliseconds,mm millimetres
P< 0.001), ventricular rate (SC= –0.081, P= 0.005),
maximum P-wave duration (SC=+0.112, P<0.001), P-
wave balance in lead V1 (SC=+0.072, P<0.001), heart
axis (SC= –0.164, P<0.001), and Sokolow-Lyon voltage
(SC= –0.097, P< 0.001) were independently associated
with BMI, as can also be observed from Tab. 3. The
R square of the multivariate model was 0.100.
Discussion
This analysis found an association between elec-
trocardiographic parameters and BMI in healthy
young (≤ 30 years) adults with a normal BMI (18.5–
25.0kg/m2). A higher BMI was independently associ-
ated with an increased P-wave duration, an increased
P-wave, a leftward shift of the heart axis, and a de-
creased Sokolow-Lyon voltage.
Left atrial enlargement (LAE) is associated with
an increased prevalence of atrial fibrillation, cardio-
vascular events and death [13]. Obesity is found to
be the most important risk factor for LAE develop-
ment in the general population [17], and is dependent
on the extent of obesity [2–6]. Furthermore, LAE is
also independently related to age, hypertension, BMI,
waist circumference, and metabolic syndrome [18],
Additionally, obesity is the strongest predictor of LAE
in hypertensive patients, and is under the influence
of race and gender [19]. These structural changes can
be observed on the twelve-lead surface ECG through
increased P-wave duration, P-wave area, and P-wave
dispersion [2–6]. Obesity-associated electrocardio-
graphic changes such as an increased P-wave dura-
tion (5–22ms) and P-wave dispersion (14–25ms) [3–6],
increased PR interval (5–13ms) [3–7] and a leftward
shift of the heart axis (11–37 degrees) compared with
adults with a normal BMI were reported [7–11]. In the
present analysis, we found a relation between BMI
and these indices of atrial size. Although no left atrial
measurement was performed these results suggest
that atrial size may also be related to BMI in healthy
individuals with a normal BMI (18.5–25.0kg/m2).
Presumably, increased epicardial and pericardial
fat, which are increased in obesity, further induce
these changes [2, 20–25]. Cardiac fat depositions were
found to have metabolic and inflammatory functions
which can contribute to the fibrotic remodelling of
the atrial tissue [1, 2, 20–25]. These fat depositions
are significantly increased in obesity and are believed
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Fig. 1 Associations of
body mass index (BMI)
with electrocardiographic
parameters. Results were
based on Analysis of Vari-
ance test between BMI dis-
tribution, and expressed as
difference in the electrocar-
diographic parameter (with
95% confidence interval)
per quartile of BMI using
a post hoc Tukey analysis.
The symbols α, ß, γ, δ, and
ε represent a significant dif-
ference (P< 0.05) compared
with that group. If no sym-
bols are present, no signif-
icance was found between
the groups. OW overweight
BMI (25.1–30.0kg/m2) group,
µV microvolt, ms millisec-
onds, mm*ms millimetre
times milliseconds
to induce the abovementioned electrocardiographic
changes [1, 2, 20–25]. Hypothetically, the volume of
epicardial and pericardial fat is also dependent on
BMI in young, non-obese individuals. This may be
an additional explanation for the association that was
observed in the present analysis between BMI and
the above-mentioned electrocardiographic changes.
Leftward shifts of the P-wave, QRS and T-wave
axes (11–37 degrees) are reported in obese patients
compared with healthy controls [7–11]. The cause of
these shifts is uncertain, but may be related to a left-
ward and more horizontal orientation of the heart
attributed to the diaphragmatic pressure from central
obesity, independent from left ventricular hypertro-
phy [7–11]. This explains the association between
lower BMI and rightward P-wave and QRS axes and
independently from left ventricular mass [11]. This is
in line with our findings and presumably, the leftward
change in heart axis that was observed in the present
analysis is caused by an increase in diaphragmatic
pressure which is dependent on BMI.
Previous reports already advocated caution when
using ECG markers for left ventricular hypertro-
phy (LVH) in obese patients [14]. The commonly
used Sokolow-Lyon voltage criteria underestimate the
prevalence of anatomic LVH in the presence of obesity,
whereas Cornell product criteria for ECG LVH appear
to provide a more accurate measure of LVH in obese
and overweight patients [12]. Obesity results in three
distinct processes that affect the surface ECG—lateral
displacement of the anatomical left ventricular (LV)
axis, increased chest wall fat and increased pericardial
fat mass—all of which decrease voltage amplitude on
the ECG [26]. We found decreased Sokolow-Lyon volt-
ages in the multivariate analysis, but no associations
with the Cornell product calculations. These find-
ings illustrate the challenge of their use as marker for
LVH even in healthy individuals with a normal BMI
(18.5–25.0kg/m2).
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Table 3 Univariate and backward linear multivariate regression model analysis
Univariate analysis Multivariate analysis
Variable USC SC R square P value USC SC P value
Age (per year) 0.079 0.139 0.019 <0.001 0.061 0.108 <0.001
Female gender –0.211 –0.054 0.003 0.056 Excluded
Temperature (°C) 0.038 0.009 0.000 0.764
Systolic blood pressure (mmHg) 0.024 0.146 0.021 <0.001 0.029 0.173 <0.001
Diastolic blood pressure (mmHg) 0.005 0.022 0.000 0.479
Ventricular rate (beats/min) –0.013 –0.076 0.006 0.006 –0.014 –0.081 0.005
Serum Sodium (mmol/l) –0.022 –0.024 0.001 0.399
Serum Potassium (mmol/l) 0.299 0.054 0.003 0.054 0.253 0.046 0.098
Serum Calcium (mmol/l) –0.735 –0.038 0.001 0.178
Maximum P-wave duration (ms) 0.020 0.130 0.017 <0.001 0.018 0.112 <0.001
P-wave balance in lead V1 (µV) 0.003 0.077 0.006 0.006 0.003 0.072 0.010
P-wave dispersion (ms) 0.001 0.009 0.000 0.740
Total P-wave area in lead V1 (mm*ms) 0.002 0.084 0.007 0.003 Excluded
PR interval (ms) 0.007 0.090 0.008 0.001 Excluded
QRS duration (ms) 0.009 0.053 0.003 0.059 Excluded
Heart axis (degrees) –0.012 –0.191 0.036 <0.001 –0.010 –0.164 <0.001
Sokolow-Lyon voltage (mm) 0.000 –0.048 0.002 0.084 0.000 –0.097 <0.001
Cornell product (mm) 5.67 *10–7 0.021 0.000 0.458
Maximum T-wave duration (ms) –0.002 –0.019 0.000 0.503
Minimum T-wave duration (ms) 0.001 0.038 0.001 0.171
T-wave dispersion (ms) –0.001 –0.045 0.002 0.107
QTcF (ms) 5.38 *10–5 0.001 0.000 0.982
Probabilities of less than 0.10 in the linear univariate regression model were added to the backward linear multivariate regression model. Results are reported
as unstandardised coefficient (USC) and standardised coefficient (SC) with the corresponding P value and the R-square value in the linear univariate regression
model. The R square of the backward linear multivariate regression model was 0.100
mV millivolt, µV microvolt, ms milliseconds,mm millimetres, QTcF corrected QT interval with the Fridericia formula
Limitations
The limitations of this study are the retrospective,
cross-sectional design, and the usage of automati-
cally calculated ECG data. The reported associations
were found to be significant in the multivariate model,
however the R square of the multivariate model was
only modest, suggesting that other co-existing factors
play a role in atrial and ventricular structural and
functional remodelling. Larger prospective cohort
studies are needed to explore the prognostic value of
these ECG findings. Additional information such as
waist circumference, cardiac dimensions, and more
detailed information about the body composition
such as fat and muscle percentages may further dif-
ferentiate between groups and provide new insights
about the cardiac changes.
Conclusion
In conclusion, we found that BMI-related discrete
electrocardiographic changes can be observed in
healthy young individuals with a normal BMI
(18.5–25.0kg/m2). These were related to an altered
atrial conduction, leftward shift of the heart axis, and
decreased Sokolow-Lyon voltage.
Conflict of interest G.J. Hassing, H.E.C. van der Wall, G.J.P.
van Westen, M.J.B. Kemme, A. Adiyaman, A. Elvan,
J. Burggraaf and P. Gal declare that they have no compet-
ing interests.
Open Access This article is distributed under the terms of
the Creative Commons Attribution 4.0 International License
(http://creativecommons.org/licenses/by/4.0/), which per-
mits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the origi-
nal author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made.
References
1. Alpert MA, Omran J, Bostick BP. Effects of Obesity on
Cardiovascular Hemodynamics, CardiacMorphology, and
VentricularFunction. CurrObesRep. 2016;5(4):424–34.
2. Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P. Obesity
andAtrial Fibrillation Prevalence, Pathogenesis, and Prog-
nosis: EffectsofWeightLossandExercise. JAmCollCardiol.
2017;70(16):2022–35.
3. VaideanGD,ManczukM,Magnani JW.Atrial electrocardio-
graphy in obesity and hypertension: Clinical insights from
thePolish-NorwegianStudy(PONS).Obesity(SilverSpring.
MD.2016;24(12):2608–14.
4. Babcock MJ, Soliman EZ, Ding J, A Kronmal R, Goff DC
Jr. Pericardial fat and atrial conduction abnormalities in
Body mass index related electrocardiographic findings in healthy young individuals with a normal body. . . 511
Original Article
the Multiethnic Study of Atherosclerosis (MESA). Obesity.
2011;19(1):179–84.
5. Liu T, Fu Z, Korantzopoulos P, et al. Effect of obesity
on p-wave parameters in a Chinese population. Ann
NoninvasiveElectrocardiol. 2010;15(3):259–63.
6. Magnani JW, Lopez FL, Soliman EZ, et al. P wave indices,
obesity, and the metabolic syndrome: the atherosclerosis
risk in communities study. Obesity. Silver Spring Md).
2012;20(3):666–72.
7. Frank S, Colliver JA, Frank A. The electrocardiogram in




9. Graner M, Pentikainen MO, Siren R, et al. Electrocardio-
graphicchangesassociatedwithinsulinresistance. NMCD.
2014;24(3):315–20.
10. Eisenstein I, Edelstein J, Sarma R, Sanmarco M, Selvester
RH. The electrocardiogram in obesity. J Electrocardiol.
1982;15(2):115–8.
11. Kurisu S, Ikenaga H, Watanabe N, et al. Electrocardio-
graphic characteristics in the underweight and obese in
accordancewith theWorldHealth Organization classifica-
tion. IJCMetabolic. Endocrine. 2015;9:61–5.
12. OkinPM, JernS,DevereuxRB,Kjeldsen SE,Dahlof B. Effect
of obesity on electrocardiographic left ventricular hyper-
trophy in hypertensive patients: the losartan intervention
for endpoint (LIFE) reduction in hypertension study. Hy-
pertension. 2000;35(1Pt1):13–8.
13. LavieCJ,DeSchutterA,PartoP,etal.ObesityandPrevalence
of Cardiovascular Diseases and Prognosis-The Obesity
ParadoxUpdated. ProgCardiovascDis. 2016;58(5):537–47.
14. Kurisu S, Ikenaga H, Watanabe N, et al. Implications of
World Health Organization classification for body mass
index on the correlations between common electrocardio-
graphic indexes for left ventricular hypertrophy and left
ventricularmass. ClinExpHypertens. 2016;38(8):715–20.
15. Garg A, Lehmann MH. Prolonged QT interval diagnosis
suppression by a widely used computerized ECG analysis
system.CircArrhythmiaElectrophysiol. 2013;6(1):76–83.
16. Poon K, Okin PM, Kligfield P. Diagnostic performance of
acomputer-basedECGrhythmalgorithm. JElectrocardiol.
2005;38(3):235–8.
17. Stritzke J, Markus MRP, Duderstadt S, et al. The Aging
Process of the Heart: Obesity Is the Main Risk Factor for
Left Atrial Enlargement During Aging. J Am Coll Cardiol.
2009;54(21):1982.
18. Cuspidi C,Meani S, Fusi V, et al. Prevalence and correlates
of left atrial enlargement in essential hypertension: role
of ventricular geometry and the metabolic syndrome: the
Evaluationof TargetOrganDamage inHypertension study.
JHypert. 2005;23(4):875–82.
19. Gottdiener JS, Reda DJ, Williams DW, Materson BJ. Left
Atrial Size in Hypertensive Men: Influence of Obesity,
Race and Age fn1fn1Financial support was provided by
the Cooperative Studies Program of the Medical Research
Service of the Department of Veterans Affairs. J Am Coll
Cardiol. 1997;29(3):651–8.
20. Fernandes-Cardoso A, Santos-Furtado M, Grindler J, et al.
EpicardialfatthicknesscorrelateswithP-waveduration,left
atrial sizeanddecreasedleftventricular systolic function in
morbidobesity. NMCD.2017;27(8):731–8.
21. Pucci G, Battista F, de Vuono S, et al. Pericardial fat, insulin
resistance, and left ventricular structure and function in
morbidobesity. Nutrition,metabolism,andcardiovascular
diseases. NMCD.2014;24(4):440–6.
22. Watanabe K, KishinoT, Sano J, et al. Relationship between
epicardialadiposetissuethicknessandearly impairmentof
left ventricular systolic function in patients with preserved
ejectionfraction.HeartVessels. 2016;31(6):1010–5.
23. Friedman DJ, Wang N, Meigs JB, et al. Pericardial fat is
associatedwith atrial conduction: the FraminghamHeart.
StudyJaha. 2014;3(2):e477.
24. Al-Rawahi M, Proietti R, Thanassoulis G. Pericardial fat





26. Okin PM, Roman MJ, Devereux RB, Kligfield P. ECG iden-
tification of left ventricular hypertrophy. Relationship
of test performance to body habitus. J Electrocardiol.
1996;29(Suppl):256–61.
27. Weinsaft JW, Kochav JD, Kim J, et al. P wave area for
quantitative electrocardiographic assessment of left atrial
remodeling. PLoSONE.2014;9(6):e99178.
28. Sokolow M, Lyon TP. The ventricular complex in left ven-
tricular hypertrophy as obtained by unipolar precordial
and limb leads. 1949. Ann Noninvasive Electrocardiol.
2001;6(4):343–68.
29. Molloy TJ, Okin PM, Devereux RB, Kligfield P. Electrocar-
diographic detection of left ventricular hypertrophy by the
simple QRS voltage-duration product. J Am Coll Cardiol.
1992;20(5):1180–6.
30. Fridericia LS. The duration of systole in an electrocardio-
gram innormal humansand inpatientswithheartdisease.
1920. AnnNoninvasiveElectrocardiol. 2003;8(4):343–51.
512 Body mass index related electrocardiographic findings in healthy young individuals with a normal body. . .
